abstract |
The present invention relates to pharmaceuticals containing amide groups, in particular amide-containing heterobicyclic metalloprotease inhibitor compounds. Specifically, the present invention provides a new class of heterobicyclic MMP-13 inhibitory compounds that exhibit increased potency compared to currently known MMP-13 inhibitors. |